Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01275365 · ClinicalTrials.gov registry record · Phase 3
Optimizing Protein Intake in Older Americans With Mobility Limitations
A Phase 3 study of Mobility Limitation, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT01275365 is a Phase 3 study of Mobility Limitation that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 92 participants, below the 253-participant average among 28 other Mobility Limitation trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01275365, a Phase 3 study of Mobility Limitation, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, placebo-controlled, parallel group, double blind, clinical trial in community dwelling, older men, 65 years of age or older, who have mobility limitation and low protein intake. The study will have a 2 X 2 factorial design, which will allow us to investigate the effects of dietary protein intake and testosterone separately and together.
Conditions Studied
Interventions
- DRUG Testosterone enanthate
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-01-19 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01275365
The ClinicalTrials.gov registry entry for NCT01275365 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 28 other Mobility Limitation trials with a reported enrollment target (64% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 1 intervention - of which Testosterone enanthate is the first listed.
NCT01275365 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01275365 about?
NCT01275365 is a clinical study titled "Optimizing Protein Intake in Older Americans With Mobility Limitations". This will be a randomized, placebo-controlled, parallel group, double blind, clinical trial in community dwelling, older men, 65 years of age or older, who have mobility limitation and low protein intake. The study will have a 2 X 2 factorial design, which will allow us to investigate the effects of...
What is the current status of trial NCT01275365?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 92 participants. The study started on 2011-05. Estimated completion is 2017-01-19.
What conditions does trial NCT01275365 study?
This clinical trial studies the following conditions: Mobility Limitation.
What interventions are being tested in trial NCT01275365?
The interventions under investigation include: Testosterone enanthate (DRUG).
Who is sponsoring clinical trial NCT01275365?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01275365 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mobility Limitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Mobility After Revascularization in Peripheral Artery Disease
RECRUITING · Phase 3
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
Impact of Brief Daily Functional Resistance Training on Lower Extremity Physical Performance
RECRUITING · Phase 2
-
Living Independence Through Functional Training
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.